Comparative proteomic and clinicopathological analysis of breast adenoid cystic carcinoma and basal-like triple-negative breast cancer [PDF]
Frontiers in Medicine, 2022 BackgroundAdenoid cystic carcinoma (ACC) is a rare type of triple-negative breast cancer that has an indolent clinical behavior. Given the substantial overlapping morphological, immunohistochemical, and molecular features with other basal-like triple ...
Qian Yao +8 more
doaj +2 more sources
The molecular landscape of breast mucoepidermoid carcinoma
Cancer Medicine, 2023 Mucoepidermoid carcinoma (MEC) of the breast is an extremely rare salivary gland‐type tumor characterized by epidermoid, basaloid, intermediate, and/or mucinous cells arranged in solid and cystic patterns.
Konstantinos Venetis +15 more
doaj +2 more sources
Mesothelin expression in triple negative breast carcinomas correlates significantly with basal-like phenotype, distant metastases and decreased survival. [PDF]
PLoS ONE, 2014 Mesothelin is a cell surface associated antigen expressed on mesothelial cells and in some malignant neoplasms. Mesothelin-targeted therapies are in phase I/II clinical trials. The clinicopathologic and prognostic significance of mesothelin expression in
Gary Tozbikian +11 more
doaj +2 more sources
Molecular Medicine, 2017 Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer tumors. Comparisons between TNBC and non-triple-negative breast cancer (nTNBC) may help to differentiate key components involved in TNBC neoplasms.
Sandra K. Santuario-Facio +18 more
doaj +2 more sources
Triple-negative breast cancer histological subtypes with a favourable prognosis [PDF]
, 2021 Triple-negative breast cancers (TNBC), as a group of tumours, have a worse prognosis than stage-matched non-TNBC and lack the benefits of routinely available targeted therapy.
European Working Group for Breast Screening Pathology
core +5 more sources
Autopsy and Case Reports, 2022 Breast sebaceous carcinoma is one of the rarest breast neoplasms, with less than 30 cases reported worldwide. Due to the rarity, the new WHO classification of breast tumors grouped these tumors among the ductal carcinoma. A detailed description of these
Natália Nobre de Alencar +3 more
doaj +2 more sources
Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnoses [PDF]
, 2021 Triple-negative breast carcinomas constitute a wide spectrum of lesions, mostly being highly aggressive. Nevertheless, some special histologic subtypes can have low malignant potential.
Cima L. +6 more
core +2 more sources
Breast, 2020 Objectives: Triple negative breast cancer (TNBC) is a heterogenous disease and associated with unfavorable outcomes. The role of sonographic features and its association with disease outcome in TNBC is uncertain.
Haoyu Wang +5 more
doaj +1 more source
Exploring the clinicopathological parameters of HER2 low breast cancers: insights from a retrospective cohort study [PDF]
Korean Journal of Clinical OncologyPurpose Breast cancer subtypes are delineated by human epidermal growth factor receptor 2 (HER2) expression, pivotal in treatment selection. HER2-positive tumors typically respond to targeted therapies, whereas HER2-negative tumors lack HER2 ...
Sana Ahuja +3 more
doaj +1 more source
GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines [PDF]
, 2011 Breakthrough Breast CancerBackground: Gonadotrophin releasing hormone (GnRH) analogs lower estrogen levels in pre-menopausal breast cancer patients. GnRH receptor (GnRH-R) activation also directly inhibits the growth of certain cells.
Sims Andrew H +27 more
core +1 more source